Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 April, 2021 11:33 IST
Natco Pharma launches Brivaracetam tablets in India
Source: IRIS | 26 Feb, 2021, 01.42PM
Rating: NAN / 5 stars.
Comments  |  Post Comment

 Natco Pharma, one of the few Indian companies to venture into new drug discovery research on February 26 announced the launch of Brivaracetam tablets under brand BRECITA in India.

Brivaracetam is indicated towards treatment of epilepsy.Brivaracetam is developed by UCB Pharma and currently marketed in India by Dr Reddy's under brand name Briviact.

NATCO's BRECITA tablets will be available in two strengths of 50mg and 100mg at significantly lower MRP prices of Rs 25 and Rs 35 per tablet respectively.

Epilepsy patients in India are estimated to be between 5-10 million, as per GEMIND guidelines.

 Shares of the company gained Rs 1.8, or 0.22%, to trade at  Rs 804.  The total volume of shares traded  was  12,019 at the BSE (12.17 p.m., Friday).

 Post Comment
Name Email
Security Code type    into this box
Related Articles
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer